Scroll Back to Top
Contact Us
Case Study

Accelerating APAC region clinical ophthalmology trials

Download PDF

Drawing on our 30+ year CRO heritage of Fortrea, formerly as part of Covance and Labcorp Drug Development, including all of the ophthalmology experience gained during the 2017 acquisition of Chiltern, we collaborated with a rapidly growing biotech in China to advance their ophthalmology program.

Book a Meeting

Choose how you like to connect.

We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.

Write to us
Book a Meeting

Prefer to send an inquiry?

Tell us about your needs and our team will follow up shortly.

* denotes required fields

Service Interest(s) *
(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif jpg jpeg png bmp txt rtf html pdf doc docx ppt pptx xls xlsx xml.

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Explore Careers at Fortrea

Join our Site Network

Learn more about participating in a Fortrea Clinical Trial

Schedule a time with a Fortrea Specialist

Connect with our team to discuss your needs and explore the right solutions for your clinical development goals — quick, clear, and hassle‑free.

Book a Meeting